Please turn JavaScript on
Lymphobob icon

Lymphobob

Want to keep yourself up to date with the latest news from Lymphobob?

Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.

You can unsubscribe at any time painlessly.

Title of Lymphobob: "Lympho Bob"

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.2 / day

Message History

Update

Hello all. As I said in my last post, I had surgery on my shoulder last week. Thought I'd provide an update. You know I don't like to more than a week without posting.

The surgery seems like it went well. The surgeon told my wife that there was extensive damage to my shoulder. The situation that caused the injury really couldn't have done the damage that it did. It was ...


Read full story

Before I get to my planned post, I want to remind you that the Follicular Lymphoma Foundation is now conducting their annual survey. It's anonymous and should only take about 10 minutes to fill out.  the survey closes on October 19. Why not do it now while you're thinking about it? Here's the link:


Read full story

The Follicular Lymphoma Foundation has posted its annual survey. Please consider responding to it. You can find it at https://survey.theflf.org/s/flf-global-patient-survey-2026.

The survey is an important source of information about FL patients and our ne...


Read full story

I'm going to give you a short, easy post today because I've been using my bad arm too much this week and it hurts. I'm scheduled for surgery in a couple of weeks, and I'm trying to get as much done as I can while I still have use of both arms.

So I found...


Read full story

The maker of Mosunetuzumab, the bispecific, released news this week that their phase III clinical trial for Mosunetuzumab and Lenalidomide seems to be an improvement over R-Squared. I think I have received about 20 different notifications from Google Alerts about ...


Read full story